Novo Nordisk says Metsera bid won't raise antitrust issues

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/6/2026

1. MU
2. APTX:CN
3. IQMX
4. SPY
5. EROC
6. MSFT
7. MSTR
8. SEER
9. FRBT
10. USO

Go back to Novo Nordisk says Metsera bid won't raise antitrust issues

Novo Nordisk earnings preview: Barclays and BofA weigh in

November 4, 2025 4:00 PM EST

Barclays and Bank of America both expect Novo Nordisk's (NYSE: NVO) third-quarter results on November 5 to come broadly in line with expectations but warn the drugmaker could lower the upper end of its 2025 guidance as prescription trends soften.

Barclays analyst Yihan Li said the bank now models +10.9% FY25 topline CER growth (generally in-line with guidance... More